IPO registrations (S-1, F-1) · Registrants
Adhera Therapeutics, Inc.
- SEC CIK
- 737207 · filings on EDGAR ↗
- Former names
- Marina Biotech, Inc. (2010–2018); MDRNA, Inc. (2008–2010); NASTECH PHARMACEUTICAL CO INC (1995–2008)
- Registration
- Form S-1, first filed 2011-03-25, last 2022-12-02; 9 initial registrations, 12 amendments
- Outcome
- Final prospectus filed 2011-05-17; declared effective 2011-03-30; withdrawal requested 2013-01-31
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- P.O. BOX 2161, Wake Forest, NC 27588
- EIN
- 11-2658569
- EDGAR entity type
- operating
- Insiders and CEO pay
- Adhera Therapeutics, Inc. on the corporate pages
On this site
- Business registration: ADHERA THERAPEUTICS, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: ADHERA THERAPEUTICS, Inc. Fuzzy (name and state)
- Business registration: ADHERA THERAPEUTICS, INC. Fuzzy (name and state)
- Business registration: ADHERA THERAPEUTICS, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: MARINA BIOTECH, INC. EXACT (EIN (EXACT))
- Form D issuer: Adhera Therapeutics, Inc. EXACT (CIK (EXACT))
- SEC filer: Adhera Therapeutics, Inc. EXACT (CIK (EXACT))
- Person page: John V Pollock Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 38
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2011-03-25 | S-1 | S-1 (registration) | Marina Biotech, Inc. | 0001193125-11-078269 ↗ |
| 2011-03-30 | EFFECT | EFFECT (declared effective) | Marina Biotech, Inc. | 9999999995-11-000835 ↗ |
| 2011-05-02 | S-1/A | S-1/A (amendment) | Marina Biotech, Inc. | 0001193125-11-120189 ↗ |
| 2011-05-10 | S-1/A | S-1/A (amendment) | Marina Biotech, Inc. | 0001193125-11-132922 ↗ |
| 2011-05-11 | S-1/A | S-1/A (amendment) | Marina Biotech, Inc. | 0001193125-11-135206 ↗ |
| 2011-05-11 | EFFECT | EFFECT (declared effective) | Marina Biotech, Inc. | 9999999995-11-001487 ↗ |
| 2011-05-17 | 424B4 | 424B4 (final prospectus) | Marina Biotech, Inc. | 0001193125-11-142313 ↗ |
| 2011-10-18 | S-1 | S-1 (registration) | Marina Biotech, Inc. | 0001193125-11-273377 ↗ |
| 2011-10-26 | S-1/A | S-1/A (amendment) | Marina Biotech, Inc. | 0001193125-11-282041 ↗ |
| 2011-10-31 | EFFECT | EFFECT (declared effective) | Marina Biotech, Inc. | 9999999995-11-003108 ↗ |
| 2011-11-02 | EFFECT | EFFECT (declared effective) | Marina Biotech, Inc. | 9999999995-11-003133 ↗ |
| 2012-12-19 | S-1 | S-1 (registration) | Marina Biotech, Inc. | 0001144204-12-068690 ↗ |
| 2013-01-31 | RW | RW (withdrawal request) | Marina Biotech, Inc. | 0001144204-13-005074 ↗ |
| 2013-02-05 | S-1/A | S-1/A (amendment) | Marina Biotech, Inc. | 0001144204-13-006123 ↗ |
| 2013-02-11 | EFFECT | EFFECT (declared effective) | Marina Biotech, Inc. | 9999999995-13-000443 ↗ |
| 2013-02-11 | EFFECT | EFFECT (declared effective) | Marina Biotech, Inc. | 9999999995-13-000444 ↗ |
| 2013-02-13 | S-1/A | S-1/A (amendment) | Marina Biotech, Inc. | 0001144204-13-008185 ↗ |
| 2013-02-14 | S-1/A | S-1/A (amendment) | Marina Biotech, Inc. | 0001144204-13-008912 ↗ |
| 2014-09-30 | EFFECT | EFFECT (declared effective) | Marina Biotech, Inc. | 9999999995-14-002897 ↗ |
| 2014-12-03 | S-1 | S-1 (registration) | Marina Biotech, Inc. | 0001571049-14-006995 ↗ |
| 2014-12-18 | EFFECT | EFFECT (declared effective) | Marina Biotech, Inc. | 9999999995-14-003740 ↗ |
| 2015-01-14 | S-1 | S-1 (registration) | Marina Biotech, Inc. | 0001571049-15-000217 ↗ |
| 2015-03-03 | S-1/A | S-1/A (amendment) | Marina Biotech, Inc. | 0001571049-15-001596 ↗ |
| 2015-04-07 | S-1/A | S-1/A (amendment) | Marina Biotech, Inc. | 0001571049-15-002652 ↗ |
| 2015-06-17 | RW | RW (withdrawal request) | Marina Biotech, Inc. | 0001571049-15-005096 ↗ |
| 2015-08-28 | S-1 | S-1 (registration) | Marina Biotech, Inc. | 0001571049-15-007124 ↗ |
| 2015-09-18 | EFFECT | EFFECT (declared effective) | Marina Biotech, Inc. | 9999999995-15-002541 ↗ |
| 2016-07-14 | EFFECT | EFFECT (declared effective) | Marina Biotech, Inc. | 9999999995-16-005143 ↗ |
| 2017-05-02 | EFFECT | EFFECT (declared effective) | Marina Biotech, Inc. | 9999999995-17-001150 ↗ |
| 2017-05-15 | EFFECT | EFFECT (declared effective) | Marina Biotech, Inc. | 9999999995-17-001288 ↗ |
| 2017-05-30 | S-1 | S-1 (registration) | Marina Biotech, Inc. | 0001493152-17-005951 ↗ |
| 2017-06-07 | S-1/A | S-1/A (amendment) | Marina Biotech, Inc. | 0001493152-17-006294 ↗ |
| 2017-06-16 | EFFECT | EFFECT (declared effective) | Marina Biotech, Inc. | 9999999995-17-001568 ↗ |
| 2017-06-26 | S-1 | S-1 (registration) | Marina Biotech, Inc. | 0001493152-17-007172 ↗ |
| 2017-07-27 | S-1/A | S-1/A (amendment) | Marina Biotech, Inc. | 0001493152-17-008199 ↗ |
| 2017-08-03 | S-1/A | S-1/A (amendment) | Marina Biotech, Inc. | 0001493152-17-008483 ↗ |
| 2017-11-22 | RW | RW (withdrawal request) | Marina Biotech, Inc. | 0001493152-17-013750 ↗ |
| 2022-12-02 | S-1 | S-1 (registration) | Adhera Therapeutics, Inc. | 0001493152-22-034344 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| QUAY STEVEN C | Director; Director,Officer | Chairman and CEO; Chairman and CSO; Chairman, President and CEO | 21 | 2006–2009 | |
| Ranker Philip C | Director; Director,Officer; Officer; Other | Chief Acctg Offcer/Interim CFO; Chief Financial Officer; Former Interim CFO & Secretary | 17 | 2006–2018 | |
| WENIG DEVIN | Director | 33 | 2006–2007 | ||
| BRANDT GORDON | Officer | Exec VP of Science and Clinica; President | 17 | 2006–2008 | |
| JOHNSON PAUL H | Officer | Sr VP of R&D, CSO | 6 | 2006–2007 | |
| WORMUTH DAVID E | Officer | Sr VP, Operations & Mfg | 8 | 2006–2007 | |
| Duffy Timothy M | Officer | Chief Business Officer; Exec. VP of Business Devp | 9 | 2006–2008 | |
| MICHELSON LESLIE D | Director | 4 | 2006–2007 | ||
| POLLOCK JOHN V | Director | 5 | 2006–2008 | person page Fuzzy | |
| Stanewick Gerald T | Director | 10 | 2006–2008 | ||
| THAW BRUCE R/FA | Director | 6 | 2006–2009 | ||
| BAYH SUSAN B | Director | 3 | 2006–2008 | ||
| BEESE J CARTER JR | Director | 3 | 2006–2007 | ||
| CROSS ALEXANDER D | Director | 4 | 2006–2008 | ||
| FERRIER IAN R | Director | 2 | 2006–2007 | ||
| HOLUBIAK MYRON Z | Director | 3 | 2006–2007 | ||
| YORK BRUCE R | Officer; Other | CFO and Secretary; Chief Actg Officer, Asst Sec.; Interim CFO, Secretary | 10 | 2006–2009 | |
| Costantino Henry R | Officer | Chief Scientific Officer; CSO - Delivery | 5 | 2007–2008 | |
| Rothman James | Director | 3 | 2008–2009 | ||
| SESSLER GREGORY | Director | 6 | 2008–2011 | ||
| PETERS DANIEL | Director | 3 | 2008–2009 | ||
| FRENCH J MICHAEL | Director,Officer; Officer | CEO; President and CEO | 9 | 2008–2015 | |
| POLISKY BARRY | Officer | Chief Scientific Officer | 4 | 2009–2011 | |
| GARCIA PETER S | Officer | Chief Financial Officer | 4 | 2009–2011 | |
| Karis James | Director | 4 | 2009–2011 | ||
| LI CHIANG J | Director | 2 | 2010 | ||
| Parker Peter | Director | 6 | 2010–2011 | ||
| Taylor Michael Douglas | Director | 3 | 2010–2011 | ||
| NOVARTIS AG | TenPercentOwner | 5 | 2010–2011 | ||
| Novartis Bioventures Ltd | TenPercentOwner | 5 | 2010–2011 | ||
| FLETCHER R JOHN | Director | 2 | 2011 | ||
| Ho Richard Theodore | Officer | Executive Vice President - R&D; Executive V.P. R&D | 3 | 2011–2014 | |
| BioMed Realty Trust Inc | TenPercentOwner | 1 | 2011 | ||
| Pryor Cashman LLP | TenPercentOwner | 3 | 2012–2014 | ||
| Loren Stefan | Director | 7 | 2012–2017 | ||
| Ramelli Joseph W. | Director; Director,Officer; Officer; Other | Chief Executive Officer; Interim CEO | 12 | 2012–2018 | |
| Geffken Daniel E. | Officer | Interim CFO | 1 | 2014 | |
| Williams Donald Allen | Director | 8 | 2014–2018 | ||
| Trieu Vuong | Director,Officer; Director,Officer,TenPercentOwner; Director,TenPercentOwner | Chairman of the Board; Executive Chairman | 10 | 2016–2018 | |
| Autotelic LLC | TenPercentOwner | 1 | 2016 | ||
| Calais Philippe | Director; Other | 4 | 2017–2018 | ||
| Hwang Larn | Officer | Chief Scientific Officer | 4 | 2017–2018 | |
| Munsif Mihir | Officer | Chief Operating Officer | 2 | 2017 | |
| Emerson Erik | Director,Officer; Officer | Chief Commercial Officer | 2 | 2017–2018 | |
| Shah Amit B. | Officer | Chief Financial Officer | 2 | 2017 | |
| Weinstein Peter D. | Officer | Chief Legal Officer | 2 | 2017 | |
| BLECH ISAAC | Director | 4 | 2017–2018 | ||
| Boris Timothy | Director | 1 | 2018 | ||
| Moscato Robert Jr. | Director,Officer; Officer | CEO; Chief Executive Officer | 3 | 2018 | |
| Hacksell Uli | Director | 2 | 2018 | ||
| Teague Robert Eric | Officer | Chief Financial Officer | 3 | 2018–2019 | |
| Phelan Nancy R. | Director; Director,Officer | CEO and Secretary | 2 | 2018–2019 | |
| Stanley Rhonda L. | Officer | SVP Finance & Accounting | 2 | 2019 | |
| KUCHARCHUK ANDREW ALBERT | Director,Officer | Chief Executive Officer | 1 | 2020 | |
| Subhan Zahed | Director | 1 | 2021 | ||
| Waerness Trond Kydd | Director | 1 | 2022 | ||
| RICE CHARLES L JR | Director | 1 | 2022 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2020-02-19 | Adhera Therapeutics, Inc. | Pharmaceuticals | $499,950 | $499,950 | 1 | 1 |
| 2019-07-11 | Adhera Therapeutics, Inc. | Pharmaceuticals | $7,000,000 | $3,239,400 | 45 | 1 |
| 2018-07-25 | Marina Biotech, Inc. | Pharmaceuticals | $11,000,000 | $1,540,000 | 9 | 1 |
| 2018-04-26 | Marina Biotech, Inc. | Biotechnology | $15,000,000 | $11,670,000 | 97 | 1 |
| 2017-11-28 | Marina Biotech, Inc. | Biotechnology | $500,000 | $500,000 | 1 | 1 |
| 2017-06-20 | Marina Biotech, Inc. | Biotechnology | $500,000 | $224,366 | 8 | 1 |
| 2016-06-22 | Marina Biotech, Inc. | Biotechnology | $300,000 | $300,000 | 2 | 1 |
| 2015-08-12 | Marina Biotech, Inc. | Biotechnology | $1,100,000 | $1,100,000 | 3 | 1 |
| 2014-03-13 | Marina Biotech, Inc. | Biotechnology | $6,000,000 | $6,000,000 | 2 | 1 |
| 2012-01-13 | Marina Biotech, Inc. | Biotechnology | $5,172,574 | $172,574 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.